A. Leask
FibroGen
Inc., South San Francisco
California 94080-6902
USA
Name/email consistency: high
- Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts. Leask, A., Abraham, D.J., Finlay, D.R., Holmes, A., Pennington, D., Shi-Wen, X., Chen, Y., Venstrom, K., Dou, X., Ponticos, M., Black, C., Bernabeu, C., Jackman, J.K., Findell, P.R., Connolly, M.K. Arthritis Rheum. (2002)
- The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Leask, A., Sa, S., Holmes, A., Shiwen, X., Black, C.M., Abraham, D.J. MP, Mol. Pathol. (2001)
- Expression of amino- and carboxyl-terminal gamma- and alpha-tubulin mutants in cultured epithelial cells. Leask, A., Stearns, T. J. Biol. Chem. (1998)